Roche on Tuesday said it will invest $50 billion in the United States over the next five years, in one of the biggest inward investment moves by companies dealing with President Donald Trump's tariffs policy.

Swiss pharmaceutical giant Roche on Tuesday said it will invest $50 billion in the United States in the next five years. The commitment includes new state-of-the art research and development sites as well as new and expanded manufacturing facilities in Indiana,

Swiss pharmaceuticals powerhouse Roche announced Monday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company, whose array of products includes cancer medicines and multiple sclerosis treatment Ocrevus,